Product
Paricalcitol
Aliases
Compound 49510, Zemplar
Name
Zemplar
INN Name
Paricalcitol
FDA Approved
Yes
14 clinical trials
8 organizations
20 indications
2 documents
Indication
Chronic Kidney DiseaseIndication
Secondary HyperparathyroidismIndication
Vitamin D InsufficiencyIndication
Chronic Kidney Disease Stage 3Indication
Chronic Kidney Disease Stage 4Indication
Pancreatic AdenocarcinomaIndication
Chronic PancreatitisIndication
Pancreatic CancerIndication
Pancreatic Ductal AdenocarcinomaIndication
Pancreatic adenocarcinomaIndication
Pancreatic MetastasesIndication
AdenocarcinomaIndication
SepsisIndication
Kidney FailureIndication
HyperphosphatemiaIndication
HypercalcemiaIndication
Pancreatic Cancer (Stage I)Indication
Stage I Pancreatic Cancer AJCC v6 and v7Clinical trial
A Phase 3, Prospective, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Paricalcitol Oral Solution for the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects Ages 0 to 9 Years With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or HemodialysisStatus: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol, and Paricalcitol Plus Low-Dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D InsufficiencyStatus: Completed, Estimated PCD: 2020-04-24
Clinical trial
A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic CancerStatus: Completed, Estimated PCD: 2015-12-01
Clinical trial
A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitisStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Phase II Pilot Trial Of Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and the Addition Of Paricalcitol Upon Disease Progression in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (NABPLAGEMD)Status: Completed, Estimated PCD: 2023-12-11
Clinical trial
Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic CancerStatus: Completed, Estimated PCD: 2022-09-30
Clinical trial
The Impact of Selective Vitamin D Receptor Activation on Clinical Outcomes in Septic Patients -a Randomised Placebo Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
Phase II Trial of Paricalcitol and Hydroxychloroquine (PH) Combination With Gemcitabine and Nab-Paclitaxel in Advanced or Metastatic Pancreatic CancerStatus: Active (not recruiting), Estimated PCD: 2024-08-14
Clinical trial
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic CancerStatus: Terminated, Estimated PCD: 2022-04-18
Clinical trial
Vitamin D Receptor Agonist Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Patients With Metastatic Pancreatic CancerStatus: Active (not recruiting), Estimated PCD: 2023-09-01
Clinical trial
A Randomized, Prospective, Cross-Over Study of Calcitriol vs. Paricalcitol in the Treatment of Mineral and Bone Disease in Hemodialysis PatientsStatus: Terminated, Estimated PCD: 2013-12-01
Clinical trial
A Phase II Pilot Trial of Nivolumab + Albumin-Bound Paclitaxel + Paricalcitol + Cisplatin + Gemcitabine (NAPPCG) In Patients With Previously Untreated Metastatic Pancreatic Ductal AdenocarcinomaStatus: Active (not recruiting), Estimated PCD: 2023-04-11
Clinical trial
Window of Opportunity for Neoadjuvant Stroma Modification in Pancreatic CancerStatus: Recruiting, Estimated PCD: 2024-03-31
Clinical trial
A Preoperative Phase 1B Study to Assess the Safety and the Immunological Effect of Pembrolizumab (Keytruda®) in Combination With Paricalcitol With or Without Chemotherapy in Patients With Resectable Pancreatic CancerStatus: Completed, Estimated PCD: 2023-01-03
Organization
Eugia US LLCOrganization
Accord Healthcare, Inc.Organization
Aurobindo Pharma LimitedDocument
DailyMed Label: ZemplarOrganization
AbbVie Inc.Organization
bryant ranch prepackDocument
DailyMed Label: ParicalcitolOrganization
TIME CAP LABORATORIES, INC.Organization
Amneal Pharmaceuticals LLCOrganization
Bionpharma Inc.